You weren’t looking for a new problem. You were looking for the number on the scale to finally move.
The weekly pen did what it was supposed to do. Appetite went quiet. The waistband eased. Then, somewhere around week eight or ten, the shower told on you.
A rope of hair in the drain you could no longer shrug off as “the usual shed.” The part that used to sit in a clean line looking… wider. The hairbrush holding more than it held in January. You started wearing it up. You stopped looking too hard in restaurant mirrors.
You blamed menopause. Or the thyroid appointment you keep moving. Or last winter. You did not, at first, blame the shot that was finally making the weight come off.
You weren’t being dramatic. Sudden shedding has a name — telogen effluvium — and women in their 40s and 50s get handed the same script every year: hormones, stress, aging. Sometimes that script is right. But two papers, in 2025 and 2026, looked somewhere else: the FDA’s own voluntary safety database. The hair-loss reports were not sprinkled evenly across every GLP-1. They were clustering.
Weekly pens are the ones lighting up FDA hair-loss reports. Older daily shots mostly did not. Pattern from FAERS analyses, 2025–2026 — not a trial incidence rate.
The finding hiding in a public FDA database
FAERS — the FDA Adverse Event Reporting System — is a mailbox, not a microscope. Doctors, pharmacists, and patients can send in side-effect reports. Nobody has to. That matters, and it is the first thing to hold onto: FAERS is a voluntary safety database. It cannot tell you how common hair loss is, and it cannot prove the drug caused it. What it can do is light up a pattern — which medicines are showing up next to a complaint more often than you’d expect.
In 2025, dermatology researchers (Godfrey and colleagues, in the Journal of the European Academy of Dermatology and Venereology) mined those reports for GLP-1 drugs. Hair-loss complaints clustered on two weekly medicines: semaglutide — that’s Ozempic and Wegovy — and tirzepatide — Mounjaro and Zepbound. The older GLP-1s they checked, including liraglutide, dulaglutide, exenatide, and lixisenatide, did not show a significant increase.
A 2026 update in the Journal of Cosmetic Dermatology counted 697 alopecia reports tied to semaglutide. Among those reports, about 1 in 4 said the hair started coming back after the drug was stopped. About 1 in 5 who restarted said the shedding came back with it.
That last part is why dermatologists sit up. Improvement after stopping, and a return after restarting, is the kind of breadcrumb you look for in a safety database. It is still not proof. But it is not a shrug, either.
Weekly pens — signal
These are the shots lighting up hair-loss reports in FAERS.
Ozempic · Wegovy
Mounjaro · Zepbound
Older GLP-1s — no significant increase
Same database. These did not light up the same way.
Saxenda · Victoza
Trulicity
Byetta / Bydureon
Adlyxin
Sources: Godfrey et al., JEADV 2025 · FAERS update, J Cosmet Dermatol 2026. Bars are a visual of “signal vs. no significant increase,” not incidence rates.
What this does not mean
- It is not proof the drug poisons follicles. Rapid weight loss itself can shove hair into a resting phase. A calorie deficit, a protein dip, a ferritin dip — any of those can empty a hairbrush. The database cannot separate “the molecule” from “the pounds coming off fast.”
- It is not a 50% chance you go bald. In the trials that actually count heads, hair loss shows up in roughly 3–5% of people on these medicines — real, but not the rule.
- It is not a reason to quit the pen tonight. The EU label for Wegovy notes that most people who reported hair loss recovered while staying on treatment. These drugs exist because the metabolic math is serious. Do not stop a prescribed GLP-1 without talking to the clinician who prescribed it.
Read the 2026 paper that way: a flare in a mailbox, not a verdict in a courtroom. Then do the unglamorous things that actually help a scalp in a calorie deficit.
What to do while you stay on the pen
Hair is not a vital organ. When you eat less — and weekly shots are very good at making you eat less — your body spends protein and iron on muscle, blood, and brain first. The part and the ponytail wait in line. That is not a character flaw. It is triage.
Appetite is low. Hair is almost all protein. Aim for a palm of it at every meal you can still finish — Greek yogurt, eggs, fish, tofu — even when the pen says you’re not hungry.
A simple blood test. Low ferritin is one of the most common, fixable reasons a woman’s part gets wider after 40. Don’t guess. Ask.
A sudden handful is worth a look. Rule out thyroid, autoimmune, traction, the things a hairbrush can’t diagnose.
In a calorie deficit, biotin, zinc, and the usual hair-skin-nail vitamins are easy to undershoot. A daily habit is not a miracle. It is how you stop running a second deficit on top of the first.
The unglamorous part: feed the line that got cut
No gummy is a substitute for a medical decision, and nothing in a bottle treats, prevents, or reverses hair loss from a GLP-1. Say that plainly, because the internet will not.
What a daily hair-skin-nails formula can do is the boring, useful thing: put biotin, zinc, and vitamins A, C, E, B5, B6, and B12 back in the rotation on the days you ate six almonds and called it lunch. That is the opening WEEM built Hair.Skin.Nails for — two gummies, once a day, plant-based, no second bathroom cabinet.
$27/month if you subscribe · $30 one-time · Cancel anytime
WEEM Hair.Skin.Nails
Two gummies a day. The list your hair keeps asking for.
- 5,000 mcg biotin per serving
- Zinc, plus vitamins A, C, E, B5, B6, B12
- Plant-based, vegan, gluten-free
- Made as a daily supplement — not a hair-loss drug
Hair, skin, and nail nutrients support the body you already have. They are not FDA-approved to treat hair loss, and they are not a reason to change a prescribed shot.
What women actually write after a couple of months
Hair cycles are slow. Most people who like these gummies say the same quiet things: less in the drain, nails that stop peeling, a couple of months before they’d call it. Below are paraphrased, representative reviews from weem.com — not medical case studies, and not claims about Ozempic, Wegovy, or any GLP-1.
“Less shedding, more length, and new growth. I’m 50. My hair has not felt this full in a long time.”
“My nails used to be paper-thin. They’re strong now. The hair that was coming out in the shower has calmed down.”
“I’ve taken them for years. The difference I notice is hair fall — it’s just not what it was.”
“Several months in, it’s filling in spots I was losing. Not overnight. But it’s doing something.”
Paraphrased from verified-style customer reviews on weem.com. Individual results vary. These comments describe a daily supplement. They do not describe treatment of GLP-1-related hair loss.
Subscribe for $27/month · one-time $30 · 60 gummies, two a day
Questions worth asking before you spiral
Do I have to quit the shot?
No. And you should not stop a prescribed GLP-1 because of a landing page. The EU Wegovy label says most people who reported hair loss recovered while staying on treatment. Bring the shed to the clinician who knows your metabolic picture. Let them weigh it against the reason you started.
Is this just aging — or menopause?
It can be. Hair changes in the 40s and 50s for reasons that have nothing to do with a pen. What’s new is the pattern in the FDA mailbox: the weekly weight-loss shots are the ones lighting up hair-loss reports; the older daily shots mostly are not. That doesn’t diagnose you. It does mean “it’s just menopause” is not the only sentence in the room.
How long before hair acts like hair again?
A resting follicle takes months, not mornings. Trial labels talk about recovery while staying on the medicine. Nutrient habits are usually judged at 8–12 weeks because that’s how long a strand needs to show up where you can see it. If it is coming out in clumps, skip the calendar and call a dermatologist.
Is WEEM FDA-approved for hair loss?
No. Hair.Skin.Nails is a dietary supplement. The FDA has not evaluated it to diagnose, treat, cure, or prevent any disease, including alopecia. It is not approved — and not intended — as a treatment for hair loss from Ozempic, Wegovy, Mounjaro, Zepbound, or any other medicine.
Why not just take a cheap biotin?
You can. WEEM’s argument is completeness and habit: 5,000 mcg biotin plus zinc and the A-C-E-B stack, in two gummies you will actually take on the days food feels optional. That is a convenience and a formula, not a prescription.
